Bavarian Nordic Future Growth
Future criteria checks 0/6
Bavarian Nordic's revenue and earnings are forecast to decline at 4.6% and 16.8% per annum respectively while EPS is expected to decline by 13.8% per annum.
Key information
-16.8%
Earnings growth rate
-13.8%
EPS growth rate
Biotechs earnings growth | 31.6% |
Revenue growth rate | -4.6% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 22 Sep 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 4,767 | 1,142 | 1,087 | 1,749 | 4 |
12/31/2024 | 4,986 | 1,121 | 476 | 2,418 | 6 |
12/31/2023 | 6,984 | 2,099 | 1,816 | 699 | 4 |
6/30/2023 | 5,533 | 1,076 | -979 | 568 | N/A |
3/31/2023 | 4,083 | 301 | -1,344 | -18 | N/A |
12/31/2022 | 3,151 | -347 | -1,162 | 220 | N/A |
9/30/2022 | 2,404 | -599 | -1,345 | -109 | N/A |
6/30/2022 | 1,849 | -693 | -1,342 | -101 | N/A |
3/31/2022 | 1,683 | -606 | -1,477 | -215 | N/A |
12/31/2021 | 1,898 | -465 | -1,417 | -358 | N/A |
9/30/2021 | 1,583 | -737 | -1,541 | -663 | N/A |
6/30/2021 | 1,693 | -629 | -1,279 | -478 | N/A |
3/31/2021 | 2,022 | -368 | -727 | 20 | N/A |
12/31/2020 | 1,852 | 278 | -135 | 572 | N/A |
9/30/2020 | 1,914 | 606 | -1,613 | 981 | N/A |
6/30/2020 | 1,499 | 481 | -1,970 | 623 | N/A |
3/31/2020 | 901 | 267 | -2,427 | 227 | N/A |
12/31/2019 | 662 | -347 | -2,947 | -276 | N/A |
9/30/2019 | 554 | -402 | -645 | -262 | N/A |
6/30/2019 | 631 | -271 | -529 | -204 | N/A |
3/31/2019 | 616 | -279 | -408 | -152 | N/A |
12/31/2018 | 501 | -362 | -500 | -289 | N/A |
9/30/2018 | 360 | -445 | -647 | -467 | N/A |
6/30/2018 | 873 | -151 | -706 | -564 | N/A |
3/31/2018 | 1,184 | 5 | -258 | -158 | N/A |
12/31/2017 | 1,370 | 181 | 137 | 216 | N/A |
9/30/2017 | 1,745 | 453 | 974 | 1,030 | N/A |
6/30/2017 | 1,463 | 225 | 816 | 880 | N/A |
3/31/2017 | 1,182 | 153 | N/A | 501 | N/A |
12/31/2016 | 1,007 | 31 | N/A | 268 | N/A |
9/30/2016 | 909 | -54 | N/A | -539 | N/A |
6/30/2016 | 536 | -202 | N/A | -345 | N/A |
3/31/2016 | 808 | -115 | N/A | -561 | N/A |
12/31/2015 | 1,021 | 59 | N/A | 105 | N/A |
9/30/2015 | 1,244 | 155 | N/A | 818 | N/A |
6/30/2015 | 1,390 | 186 | N/A | 815 | N/A |
3/31/2015 | 1,166 | 70 | N/A | 1,018 | N/A |
12/31/2014 | 1,217 | 26 | N/A | 339 | N/A |
9/30/2014 | 1,013 | -99 | N/A | -63 | N/A |
6/30/2014 | 1,107 | -61 | N/A | -105 | N/A |
3/31/2014 | 1,293 | -12 | N/A | 180 | N/A |
12/31/2013 | 1,213 | -47 | N/A | 147 | N/A |
9/30/2013 | 1,142 | -82 | N/A | 32 | N/A |
6/30/2013 | 1,127 | -81 | N/A | 160 | N/A |
3/31/2013 | 1,055 | -245 | N/A | -44 | N/A |
12/31/2012 | 1,017 | -240 | N/A | 20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BV3's earnings are forecast to decline over the next 3 years (-16.8% per year).
Earnings vs Market: BV3's earnings are forecast to decline over the next 3 years (-16.8% per year).
High Growth Earnings: BV3's earnings are forecast to decline over the next 3 years.
Revenue vs Market: BV3's revenue is expected to decline over the next 3 years (-4.6% per year).
High Growth Revenue: BV3's revenue is forecast to decline over the next 3 years (-4.6% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BV3's Return on Equity is forecast to be high in 3 years time